Panmed Pharmaceuticals, Inc. v. United States

56 Cust. Ct. 689, 1966 Cust. Ct. LEXIS 1981
CourtUnited States Customs Court
DecidedMarch 31, 1966
DocketR.D. 11163; Entry No. 903669
StatusPublished
Cited by1 cases

This text of 56 Cust. Ct. 689 (Panmed Pharmaceuticals, Inc. v. United States) is published on Counsel Stack Legal Research, covering United States Customs Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Panmed Pharmaceuticals, Inc. v. United States, 56 Cust. Ct. 689, 1966 Cust. Ct. LEXIS 1981 (cusc 1966).

Opinion

Wilson, Judge:

This is an appeal for reappraisement of certain merchandise invoiced as “Bactekial PowdeR or Vitamin B12 Conc. 705 MG/KG,” manufactured by Pierrel S.p.A. of Milan, Italy, and exported therefrom on or about December 30, 1960.

The merchandise in question was appraised at $20 per net gram content of vitamin B-12, less $93.35 nondutiable charges, on the basis of export value under the provisions of section 402(b) of the Tariff [690]*690Act of 1930, as amended by the Customs Simplification Act of 1956, T.D. 54165. It is not disputed that export value, as adopted by the appraiser, is the proper basis for appraisement of the involved merchandise. However, the plaintiff herein claims that the actual value of the merchandise for tariff purposes is $7 per net gram of vitamin B-12 content, less the nondutiable charges.

Section 402(b) of the Tariff Act of 1930, as amended, supra, provides as follows:

(b) ExpoRT Value. — For the purposes of this section, the export value of imported merchandise shall be the price, at the time of exportation to the United States _ of the merchandise undergoing ap-praisement, at which such or similar merchandise is freely sold or, in the absence of sales, offered for sale in the principal markets of the country of exportation, in the usual wholesale quantities and in the ordinary course of trade, for exportation to the United States, plus, when not included in such price, the cost of all containers and coverings of whatever nature and all other expenses incidental to placing the merchandise in condition, packed ready for shipment to the United States.

There was received in evidence “The file as transmitted” (R. 12-14). Among the papers so admitted in evidence was a United States Customs Laboratory Report, No. S 2621 of February 28, 1961, which, so far as is pertinent, reads as follows:

Based on our analysis and on the invoice information, the sample is a feed grade of Vitamin B12. * * *

It is similar to, and 5.4 times as strong as, Vitamin B12, Feed Grade, 60 mg/lb., made by Grain Processing Corp.

There was also received in evidence as plaintiff’s exhibit 1 an affidavit of Niccolo’ Visconti, president and general manager of Pierrel S.p.A., Via Turati, Milan, Italy, the manufacturer of the merchandise at bar. The affiant therein, who stated that he had negotiated with the plaintiff for the purchase and sale of “Vitamin B-12 Bacterial Powder,” set forth his educational background and his familiarity with the imported merchandise, “having supervised and seen the processes actually conducted.” He described the process of manufacturing the “Vitamin B-12 Bacterial Powder” as follows:

The anaerobial micro-organism employed in the fermentation process is cultivated on a substratum (culture broth) containing dextrose, com steep liquor, com seed oil and mineral salts, without fermentation precursors. This culture medium is introducted into big iron fermen-tors, cooked and sterilized.

The sterilized 'broth is inoculated with our micro-organism and fermented for a period of four days. As soon as the optimum of the fermentation is reached, fermentation 'is stopped and the broth is cem-[691]*691trifuged in order to collect the micro-organism cells containing the Vitamin B-12. The slurry is passed onto a drum-dryer from which the Bacterial Powder is collected.

The foregoing Bacterial Powder contains 705 mg of Vitamin B-12 per kilo of powder and this was the merchandise sold to Panmed Pharmaceuticals Inc. * * *

The aforementioned documentary exhibits comprised the plaintiff’s affirmative case. The defendant, on its part, offered the oral testimony of two witnesses.

Defendant’s first witness was Mr. Orva Phillips who, at the time of trial, had been employed for the past 7 years as a chemist with the Bureau of Customs at its New York Customs Laboratory. He stated that his duties in such capacity were to analyze submitted samples from importations, stating “coal tar samples are usually my specialty” (R. 26). The witness testified that he 'had analyzed a sample of the imported merchandise (defendant’s exhibit A) and stated that he had determined that it contained vitamin B-12; and that he had compared the sample with a domestic sample of vitamin B-12 manufactured by Grain Processing Oorp., Muscatine, Iowa. (Defendant’s exhibit B.) A customs laboratory report of the analysis of the sample made by defendant’s witness (report S 2621) indicates that defendant’s exhibit B contained 60 milligrams of vitamin B-12 per pound which Mr. Phillips stated was equivalent to 132 milligrams per kilogram (R. 29-30). He stated, however, that all he did was to determine that defendant’s exhibit A contained vitamin B-12 (R. 30).

Defendant’s second witness was Dr. Caesar Bottone who stated that he was president of Panmed Pharmaceuticals, Inc., plaintiff herein. He testified that his duties entailed the supervision of “the whole business activity of the company” (R. 31) and that, in such capacity, he actually buys and sells merchandise and negotiates for the purchase of merchandise (R. 31-32). The record discloses that defendant’s witness had acquired an education in Italy, having graduated from the University of Bologna in 1953 as a medical doctor. Subsequently, upon his return to the United States, Dr. Bottone had become engaged in the activity of buying and selling chemicals and chemical pharmaceuticals.

Dr. Bottone testified that he was familiar with “Cyanocobalamine,” which is more commonly known as “Vitamin B12 Crystalline USP.” He stated that he was familiar with the various uses of vitamin B-12 in its various forms (R. 32-33). Defendant’s witness further testified that he had arranged and negotiated the transaction for the purchase of the imported merchandise from the manufacturer and that, in such ordering, he did not specify any special requirements as to the potency of the merchandise he was to buy. He ordered “Vitamin B12 Feed [692]*692Grade, any potency from 800 milligrams per kilo, on up” (R. 34). Tbe witness stated tliat lie was also familiar with, the “Feed Grade Concentrates of Vitamin B12” and expressed the opinion that there is no standard content per milligram per kilo of a vitamin B-12 feed grade concentrate “from a technical point of view,” nor is there any standard concentration or potency in the use of vitamin B-12 feed grade — “It may be diluted or concentrated at will and in accordance with the uses that are marked for the product” (R. 34-35). Dr. Bottone conceded, however, that he had no personal familiarity or experience with the uses of vitamin B-12 feed grade concentrates (R. 35). He stated that neither he nor anyone in his organization had any personal interest in or was employed by Pierrel, the manufacturer-exporter of the merchandise under consideration (R. 35-37). With reference to the process of manufacturing of the imported merchandise as described by Mr. Visconti (plaintiffs exhibit 1), the witness testified that while he was not a biochemist or a microbiologist and that he was not familiar in a technical sense with the process described in plaintiff’s exhibit 1, “I do understand it, but I have never done this myself” (R. 39-40).

On cross-examination, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

H. M. Young Associates, Inc. v. United States
60 Cust. Ct. 842 (U.S. Customs Court, 1968)

Cite This Page — Counsel Stack

Bluebook (online)
56 Cust. Ct. 689, 1966 Cust. Ct. LEXIS 1981, Counsel Stack Legal Research, https://law.counselstack.com/opinion/panmed-pharmaceuticals-inc-v-united-states-cusc-1966.